Histologic Subtype of Metastatic Renal Cell Carcinoma Predicts Response to Combined Immunochemotherapy with Interleukin 2, Interferon α and 5-Fluorouracil-Reference-Cited by-同舟云学术

Histologic Subtype of Metastatic Renal Cell Carcinoma Predicts Response to Combined Immunochemotherapy with Interleukin 2, Interferon α and 5-Fluorouracil

Published:2007-06 Issue:6 Volume:51 Page:1625-1632
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Herrmann Edwin,Brinkmann Olaf Anselm,Bode Marc-Eric,Bierer Stefan,Köpke Thomas,Bögemann Martin,Hertle Lothar,Wülfing Christian

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006

2. Rising incidence of renal cell cancer in the United States;Chow;JAMA,1999

3. Metastatic renal cell carcinoma;Flanigan;Curr Treat Options Oncol,2003

4. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial;Mickisch;Lancet,2001

5. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer;Flanigan;N Engl J Med,2001

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Papillary Renal Cell Carcinoma: Current Evidence and Future Directions;Kidney Cancer;2024-05-07

2. Systematic analysis of RNASET2 gene as a potential prognostic and immunological biomarker in clear cell renal cell carcinoma;BMC Cancer;2023-09-07

3. Changes in expressions of ADAM9, 10, and 17 as well as α-secretase activity in renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2017-01

4. Neuropeptide Levels as well as Neprilysin Activity Decrease in Renal Cell Carcinoma;Cancer Microenvironment;2016-10-19

5. Temsirolimus in Daily Use: Results of a Prospective Multicentre Noninterventional Study of Patients with Metastatic Kidney Cancer;European Urology;2014-08